These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36305426)

  • 21. A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications.
    Min YQ; Huang M; Feng K; Jia Y; Sun X; Ning YJ
    Mol Cell Proteomics; 2023 Jul; 22(7):100579. PubMed ID: 37211047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells.
    Trionfetti F; Alonzi T; Bontempi G; Terri M; Battistelli C; Montaldo C; Repele F; Rotili D; Valente S; Zwergel C; Matusali G; Maggi F; Goletti D; Tripodi M; Mai A; Strippoli R
    Front Cell Infect Microbiol; 2023; 13():1257683. PubMed ID: 38162580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.
    Davies JP; Almasy KM; McDonald EF; Plate L
    ACS Infect Dis; 2020 Dec; 6(12):3174-3189. PubMed ID: 33263384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and MortaparibPlus.
    Kumar V; Sari AN; Meidinna HN; Dhanjal JK; Subramani C; Basu B; Kaul SC; Vrati S; Sundar D; Wadhwa R
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34647577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.
    Jiang L; Xiao M; Liao QQ; Zheng L; Li C; Liu Y; Yang B; Ren A; Jiang C; Feng XH
    mSystems; 2023 Aug; 8(4):e0013523. PubMed ID: 37314180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition.
    Sanna V; Satta S; Hsiai T; Sechi M
    Eur J Med Chem; 2022 Mar; 231():114121. PubMed ID: 35114539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.
    Chen F; Shi Q; Pei F; Vogt A; Porritt RA; Garcia G; Gomez AC; Cheng MH; Schurdak ME; Liu B; Chan SY; Arumugaswami V; Stern AM; Taylor DL; Arditi M; Bahar I
    Mol Syst Biol; 2021 Aug; 17(8):e10239. PubMed ID: 34339582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular modelling identification of phytocompounds from selected African botanicals as promising therapeutics against druggable human host cell targets of SARS-CoV-2.
    Uhomoibhi JO; Shode FO; Idowu KA; Sabiu S
    J Mol Graph Model; 2022 Jul; 114():108185. PubMed ID: 35430474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.
    Hum C; Loiselle J; Ahmed N; Shaw TA; Toudic C; Pezacki JP
    Drugs; 2021 Apr; 81(5):517-531. PubMed ID: 33638807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs.
    Eskandarzade N; Ghorbani A; Samarfard S; Diaz J; Guzzi PH; Fariborzi N; Tahmasebi A; Izadpanah K
    Comput Biol Med; 2022 Jul; 146():105575. PubMed ID: 35533462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2.
    Chen IP; Longbotham JE; McMahon S; Suryawanshi RK; Khalid MM; Taha TY; Tabata T; Hayashi JM; Soveg FW; Carlson-Stevermer J; Gupta M; Zhang MY; Lam VL; Li Y; Yu Z; Titus EW; Diallo A; Oki J; Holden K; Krogan N; Fujimori DG; Ott M
    Cell Rep; 2022 Jul; 40(3):111088. PubMed ID: 35839775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of phytochemicals in Qingfei Paidu decoction for the treatment of coronavirus disease 2019 by targeting the virus-host interactome.
    Li Y; Wu Y; Li S; Li Y; Zhang X; Shou Z; Gu S; Zhou C; Xu D; Zhao K; Tan S; Qiu J; Pan X; Li L
    Biomed Pharmacother; 2022 Dec; 156():113946. PubMed ID: 36411632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug repurposing screens identify chemical entities for the development of COVID-19 interventions.
    Bakowski MA; Beutler N; Wolff KC; Kirkpatrick MG; Chen E; Nguyen TH; Riva L; Shaabani N; Parren M; Ricketts J; Gupta AK; Pan K; Kuo P; Fuller M; Garcia E; Teijaro JR; Yang L; Sahoo D; Chi V; Huang E; Vargas N; Roberts AJ; Das S; Ghosh P; Woods AK; Joseph SB; Hull MV; Schultz PG; Burton DR; Chatterjee AK; McNamara CW; Rogers TF
    Nat Commun; 2021 Jun; 12(1):3309. PubMed ID: 34083527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.
    Behura A; Naik L; Patel S; Das M; Kumar A; Mishra A; Nayak DK; Manna D; Mishra A; Dhiman R
    Biochim Biophys Acta Mol Basis Dis; 2023 Mar; 1869(3):166634. PubMed ID: 36577469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4).
    Kaur R; Tada T; Landau NR
    mBio; 2023 Aug; 14(4):e0109023. PubMed ID: 37382452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.